Acetic Acid

Acetic Acid

SCHEMBL7531107

C1CCCNNNCC1.CC(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
GLI1 P08151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL3991283 1.00 FFAR3 (0.39) FFAR3LCKFYNGLI1
Acetic Acid SCHEMBL7210352 1.00 FFAR3 (0.39) FFAR3LCKFYNGLI1
Acetic Acid SCHEMBL2090071 0.94 FFAR3 (0.39) FFAR3LCKFYNGLI1
Acetic Acid SCHEMBL1528008 0.94 FFAR3 (0.39) FFAR3LCKFYNGLI1
Acetic Acid SCHEMBL1566799 0.94 FFAR3 (0.39) FFAR3LCKFYNGLI1
Acetic Acid SCHEMBL5711032 0.92 FFAR3 (0.37) FFAR3LCKFYN
Acetic Acid SCHEMBL5554975 0.92 FFAR3 (0.37) FFAR3LCKFYN
Glutarate SCHEMBL25307838 0.85 SLC22A6 (0.44)
Glutarate SCHEMBL25260627 0.80 SLC22A6 (0.44)
Butanedione SCHEMBL7163397 0.80 TSHR (0.41) GLI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0805815-B1 Use of bismuth compounds for the manufacture of medicaments for the treatment of gastric disorders caused by Helicobacter pylori NYCOMED IMAGING AS (NO) 2002-04-10 EP disclosed
US-6303101-B1 TREATING A GASTROINTESTINAL DISORDER, ESPECIALLY AN ULCER CAUSED BY HELIOBACTER PYLORI. NYCOMED IMAGING AS (NO) 2001-10-16 US disclosed
US-6117412-A ADMINISTERING BISMUTH COMPOUND CONTAINING ADDITIONAL HEAVY ATOM AS CONTRAST ENHANCER; X-RAYS, MAGNETIC RESONANCE, ULTRASOUND, AND SCINTIGRAPHIC IMAGING NYCOMED IMAGING AS (NO) 2000-09-12 US disclosed
US-5932190-A Multinuclear complexes for X-ray imaging NYCOMED SALUTAR, INC. (US) 1999-08-03 US disclosed
US-5817289-A Non-cluster type bismuth compounds NYCOMED IMAGING AS (NO) 1998-10-06 US disclosed
EP-0805815-A1 BISMUTH COMPOUNDS NYCOMED IMAGING A/S (NO) 1997-11-12 EP disclosed
US-5614168-A Multinuclear complexes for X-ray imaging NYCOMED SALUTAR INC. (US) 1997-03-25 US disclosed
WO-1996022994-A1 BISMUTH COMPOUNDS NYCOMED IMAGING A/S (NO) 1996-08-01 WO disclosed
US-5482699-A Multinuclear complexes for x-ray imaging NYCOMED SALUTAR INC. (US) 1996-01-09 US disclosed
US-5458869-A Used as contrast enhancing agents for medical diagnosis; tungsten complex NYCOMED SALUTAR INC. (US) 1995-10-17 US disclosed
EP-0645146-A1 Contrast media NYCOMED IMAGING AS (NO) 1995-03-29 EP disclosed
EP-0577675-A1 CONTRAST MEDIA NYCOMED SALUTAR, INC. (US) 1994-01-12 EP disclosed
EP-0521977-A1 CONTRAST MEDIA. NYCOMED IMAGING AS (NO) 1993-01-13 EP disclosed
WO-1992017215-A1 CONTRAST MEDIA NYCOMED SALUTAR, INC. (US) 1992-10-15 WO disclosed
WO-1991014460-A1 CONTRAST MEDIA COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) 1991-10-03 WO disclosed